HOW IT WORKS
What are these Treatments? How do they work? Why Should I Consider These Treatments?
What Is Semaglutide (GLP-1)?
Semaglutide is a weekly, doctor-prescribed medication custom-blended for each patient. It mimics the action of a natural hormone called glucagon-like peptide-1 (GLP-1), helping you achieve your weight loss goals effectively and sustainably.
- How It Works:
- Appetite Regulation: Semaglutide targets the brain’s appetite center to create a feeling of fullness, reduce hunger, and control cravings for unhealthy foods, sugar, and alcohol.
- Slower Stomach Emptying: By slowing down digestion, it helps you feel satisfied longer, leading to lower calorie intake.
- Resetting Your Body’s Set Point: It assists in lowering your natural weight range, making it easier to maintain long-term results.
- Why It’s Effective:
- Semaglutide is the FDA-approved active ingredient in Ozempic® and Wegovy®.
- Compounded Semaglutide, offered by our specialized pharmacies, contains the same active ingredient but is up to 80% more affordable than branded alternatives while maintaining rigorous safety and quality standards.
- It’s the only GLP-1 agonist shown to sustain a 15% weight loss at two years.


What Is Tirzepatide?
Tirzepatide is a dual-action peptide targeting both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, offering enhanced metabolic benefits compared to Semaglutide alone.
- How It Works:
- Dual Appetite Control: It regulates appetite by signaling fullness and reducing hunger even more effectively than Semaglutide.
- Metabolic Benefits: Tirzepatide supports carbohydrate, lipid, and protein metabolism, optimizing your body’s energy use.
- Sustained Fullness: Like Semaglutide, it slows stomach emptying, helping you eat less and feel full longer.
- Why It’s Effective:
- Tirzepatide is the FDA-approved active ingredient in Zepbound® and Mounjaro®.
- Compounded Tirzepatide provides the same active ingredient as branded versions but at a fraction of the cost. It’s equally effective and undergoes stringent testing for safety and quality.
- It’s the only GLP-1 agonist shown to sustain 20% weight loss at two years.
Why Consider These Treatments?
Overweight and obesity affect Nearly 70% of adults in the United States are overweight or obese, increasing the risk of heart disease, stroke, diabetes, and certain cancers. Losing just 5–10% of body weight through diet and exercise can significantly reduce these risks.
Our advanced medications, combined with a personalized plan, offer an effective, affordable solution to help you take control of your health and achieve lasting weight loss.
Your journey to a healthier, happier you starts here.
